Recent Posts
Looking ahead to PDUFA VI

Next Monday, PhRMA and BIO will participate alongside patient advocates and key stakeholders in the U.S. Food and Drug Administration’s (FDA) public meeting on the reauthorization of the Prescription...
Read More